PGxO and PGxLOD: a reconciliation of pharmacogenomic knowledge of various provenances, enabling further comparison
Pierre MonniniD, Joël LegrandiD, Graziella Husson, Patrice Ringot, Andon TchechmedjieviD, Clément JonquetiD, Amedeo NapoliiD, Adrien CouletiD
Abstract
BackgroundPharmacogenomics (PGx) studies how genomic variations impact variations in drug response phenotypes. Knowledge in pharmacogenomics is typically composed of units that have the form of ternary relationships gene variant - drug - adverse event. Such a relationship states that an adverse event may occur for patients having the speciifed gene variant and being exposed to the specified drug. State-of-the-art knowledge in PGx is mainly available in reference databases such as PharmGKB and reported in scientific biomedical literature. But, PGx knowledge can also be discovered from clinical data, such as Electronic Health Records (EHRs), and in this case, may either correspond to new knowledge or confirm state-of-the-art knowledge that lacks \"clinical counterpart\" or validation. For this reason, there is a need for automatic comparison of knowledge units from distinct sources.\n\nResultsIn this article, we propose an approach, based on Semantic Web technologies, to represent and compare PGx knowledge units. To this end, we developed PGxO, a simple ontology that represents PGx knowledge units and their components. Combined with PROV-O, an ontology developed by the W3C to represent provenance information, PGxO enables encoding and associating provenance information to PGx relationships. Additionally, we introduce a set of rules to reconcile PGx knowledge, i.e. to identify when two relationships, potentially expressed using different vocabularies and level of granularity, refer to the same, or to different knowledge units. We evaluated our ontology and rules by populating PGxO with knowledge units extracted from PharmGKB (2,701), the literature (65,720) and from discoveries reported from EHR analysis studies (only 10, manually extracted); and by testing their similarity. We called PGxLOD (PGx Linked Open Data) the resulting knowledge base that represents and reconciles knowledge units of those various origins.\n\nConclusionsThe proposed ontology and reconciliation rules constitute a first step toward a more complete framework for knowledge comparison in PGx. In this direction, the experimental instantiation of PGxO, named PGxLOD, illustrates the ability and difficulties of reconciling various existing knowledge sources.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 32
- FWCI
- 1.74
- Field percentile
- top 15%
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- PGxCorpus: a Manually Annotated Corpus for Pharmacogenomics
Joël Legrand, Romain Gogdemir, … Adrien Coulet·Scientific DataPeer-reviewed·Jan 2, 2020
- A LARGE-SCALE PHARMACOGENOMIC KNOWLEDGE GRAPH FOR DRUG-GENE-VARIANT-DISEASE DISCOVERY
Muhammad Omar Faruk·medRxiv·Sep 24, 2025
- preSCRIPT: Large-scale prescription search and annotation engine for pharmacogenomic studies
Maria Pieczarka, Paweł Pieńkowski, … Michał Korostyński·Pharmacological ReportsPeer-reviewed·Aug 24, 2026
- Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?
Moira Verbelen, Michael E Weale, Cathryn M Lewis·bioRxiv·Jul 23, 2016
- Clinical Impact of Pharmacogenetic Risk Variants in a Large Chinese Cohort
Chun-Yu Wei, Ming‐Shien Wen, … Chien‐Ming Lin·Nature CommunicationsPeer-reviewed·Jul 9, 2025
- Genotype-predicted drug response phenotypes and their co-occurrence with dispensed medicines among 738,531 participants in the UK Our Future Health study
Christopher T. Rentsch, Krishnan Bhaskaran, … Munir Pirmohamed·medRxiv·Aug 12, 2026